Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Preferred Dividend Payments (2023 - 2025)

Mesoblast's (MEOBF) quarterly Preferred Dividend Payments came in at $2.0 million in Q2 2025, little changed year-over-year from $2.0 million in Q2 2024, and little changed quarter-over-quarter from $2.0 million in Q2 2024.

Analysis

Mesoblast (MEOBF) Preferred Dividend Payments (2023 - 2025) Analysis & Trends

Mesoblast has disclosed Preferred Dividend Payments across 3 years of filings, most recently posting $2.0 million for Q2 2025.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Krystal Biotech 10.13 Bn 9.29 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.23 Bn 5.23 Bn - -
3 Iovance Biotherapeutics 3.82 Bn 3.52 Bn 55.72 Mn -
4 Legend Biotech 3.68 Bn 2.72 Bn 251.50 Mn -
5 uniQure 3.08 Bn 3.08 Bn 5.49 Mn -
6 Beam Therapeutics 2.67 Bn 2.67 Bn - -
7 Precigen 2.43 Bn 2.43 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.33 Bn 1.54 Bn 251.87 Mn -
9 Vericel 2.00 Bn 1.84 Bn 56.40 Mn -
10 Mesoblast 246.02 Mn 143.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 2.03 Mn
Jun 30, 2024 2.02 Mn
Jun 30, 2023 2.02 Mn